Domestic Company’s Products Help Treat Cancer Patients

A domestic knowledge-based company active in the field of stem cells is able to process all types of immune and blood cells, which assists in the early detection of drug resistance in cancer patients. 
Kian Immune Cell Company is a pioneer in the production of advanced cellular products that process immune, hematopoietic and genetically modified cells, according to the company’s CEO.
“Haploidentical Natural Killer [NK] cells and allogeneic NK cells produced with off-the-shelf method for cancer immunotherapy and tumor-specific anticancer drug sensitivity test kits for personalized medicine are among the most important products of this company,” Marzieh Ebrahimi was also quoted as saying by the news portal of the Vice Presidency for Science and Technology.
Ebrahimi added that with the establishment of the allogeneic NK cell bank, the company can also become active in the field of cell therapy for brain tumors, for which two Phase 1 clinical trials have been conducted.